Mostrar el registro sencillo del ítem
Effect of daily intake of a low-alcohol orange beverage on cardiovascular risk factors in hypercholesterolemic humans
dc.contributor.author | Cerrillo I. | |
dc.contributor.author | Escudero-López B. | |
dc.contributor.author | Ortega A. | |
dc.contributor.author | Martín F. | |
dc.contributor.author | Fernández-Pachón M.S. | |
dc.date.accessioned | 2020-09-02T22:14:48Z | |
dc.date.available | 2020-09-02T22:14:48Z | |
dc.date.issued | 2019 | |
dc.identifier | 10.1016/j.foodres.2018.08.008 | |
dc.identifier.citation | 116, , 168-174 | |
dc.identifier.issn | 09639969 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/3990 | |
dc.description | Oxidative stress, inflammation status, endothelial dysfunction, and imbalanced lipid metabolism play a major role in cardiovascular disease. Bioactive compounds and moderate alcohol consumption have been associated with decreased cardiovascular risk. This study aimed to evaluate the effect on cardiovascular risk factors of a low-alcohol beverage derived from the alcoholic fermentation of orange juice. Eighteen individuals with moderately high cholesterol levels were randomly assigned to an experimental group (n = 9) who drank 500 mL/day of the orange beverage for 2 weeks or a control group (n = 9) who drank no orange beverage. Blood samples were drawn at the beginning and end of the study period. Consumption of the beverage significantly decreased plasma levels of total cholesterol (−15.6%), LDL-cholesterol (−17.8%), LDL-cholesterol/HDL-cholesterol ratio (−21.4%), catalase (−25.5%), TBARS (−42.6%), and sVCAM-1 (−5.8%). This orange beverage would have a potential capacity to improve cardiovascular risk in hypercholesterolemic humans, supporting its future consideration as a functional beverage. © 2018 Elsevier Ltd | |
dc.language.iso | en | |
dc.publisher | Elsevier Ltd | |
dc.subject | Alcohol | |
dc.subject | Bioactive compounds | |
dc.subject | Cardiovascular risk factor | |
dc.subject | Hypercholesterolemic humans | |
dc.subject | Lipid profile | |
dc.subject | Orange | |
dc.subject | Alcohols | |
dc.subject | Cholesterol | |
dc.subject | Citrus fruits | |
dc.subject | Fruit juices | |
dc.subject | Bioactive compounds | |
dc.subject | Cardio-vascular risk factors | |
dc.subject | Hypercholesterolemic humans | |
dc.subject | Lipid profile | |
dc.subject | Orange | |
dc.subject | Alcoholic beverages | |
dc.subject | antioxidant | |
dc.subject | catalase | |
dc.subject | high density lipoprotein cholesterol | |
dc.subject | low density lipoprotein cholesterol | |
dc.subject | thiobarbituric acid reactive substance | |
dc.subject | adult | |
dc.subject | alcoholic beverage | |
dc.subject | blood | |
dc.subject | cardiovascular disease | |
dc.subject | complication | |
dc.subject | female | |
dc.subject | fruit and vegetable juice | |
dc.subject | human | |
dc.subject | hypercholesterolemia | |
dc.subject | inflammation | |
dc.subject | male | |
dc.subject | metabolism | |
dc.subject | oxidative stress | |
dc.subject | risk factor | |
dc.subject | sweet orange | |
dc.subject | Adult | |
dc.subject | Alcoholic Beverages | |
dc.subject | Antioxidants | |
dc.subject | Cardiovascular Diseases | |
dc.subject | Catalase | |
dc.subject | Cholesterol, HDL | |
dc.subject | Cholesterol, LDL | |
dc.subject | Citrus sinensis | |
dc.subject | Female | |
dc.subject | Fruit and Vegetable Juices | |
dc.subject | Humans | |
dc.subject | Hypercholesterolemia | |
dc.subject | Inflammation | |
dc.subject | Male | |
dc.subject | Oxidative Stress | |
dc.subject | Risk Factors | |
dc.subject | Thiobarbituric Acid Reactive Substances | |
dc.title | Effect of daily intake of a low-alcohol orange beverage on cardiovascular risk factors in hypercholesterolemic humans | |
dc.type | Article |